IFNA2 and melanoma: HT168-M1 melanoma cells, grown as monolayer cultures, were cultured for 6 weeks in the presence of escalating doses (10,000 U/mL, then 20,000 U/mL) of IFN-α2a, followed by testing for sensitivity in vitro treatment with IFN-α2a using the MTT assay.